BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11960694)

  • 1. Activation of the p53 tumor suppressor protein.
    Vousden KH
    Biochim Biophys Acta; 2002 Mar; 1602(1):47-59. PubMed ID: 11960694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of p53 activation--spoilt for choice.
    Vousden KH
    J Cell Sci; 2006 Dec; 119(Pt 24):5015-20. PubMed ID: 17158908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging picture of p53.
    Selter H; Montenarh M
    Int J Biochem; 1994 Feb; 26(2):145-54. PubMed ID: 8174748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and activities of the p53 tumour suppressor protein.
    Bálint E E; Vousden KH
    Br J Cancer; 2001 Dec; 85(12):1813-23. PubMed ID: 11747320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53: fighting cancer.
    Selivanova G
    Curr Cancer Drug Targets; 2004 Aug; 4(5):385-402. PubMed ID: 15320716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relevance of p53 protein and its mutations for novel strategies in cancer therapy].
    Müller P; Nenutil R; Vojtĕsek B
    Cas Lek Cesk; 2004; 143(5):313-7. PubMed ID: 15305766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ-line-derived hinge domain p53 mutants have lost apoptotic but not cell cycle arrest functions.
    Aurelio ON; Cajot JF; Hua ML; Khwaja Z; Stanbridge EJ
    Cancer Res; 1998 May; 58(10):2190-5. PubMed ID: 9605765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor p53: regulation and function.
    Somasundaram K
    Front Biosci; 2000 Apr; 5():D424-37. PubMed ID: 10762600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
    Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H
    Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppressor p53: implications for tumor development and prognosis.
    Kirsch DG; Kastan MB
    J Clin Oncol; 1998 Sep; 16(9):3158-68. PubMed ID: 9738588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of p53 in metabolism and invasion.
    Vousden KH
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):511-7. PubMed ID: 19442244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NF-kappaB in p53-mediated programmed cell death.
    Ryan KM; Ernst MK; Rice NR; Vousden KH
    Nature; 2000 Apr; 404(6780):892-7. PubMed ID: 10786798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
    Sigal A; Rotter V
    Cancer Res; 2000 Dec; 60(24):6788-93. PubMed ID: 11156366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53.
    Komarova EA; Diatchenko L; Rokhlin OW; Hill JE; Wang ZJ; Krivokrysenko VI; Feinstein E; Gudkov AV
    Oncogene; 1998 Sep; 17(9):1089-96. PubMed ID: 9764819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
    de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
    Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
    Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
    Rowan S; Ludwig RL; Haupt Y; Bates S; Lu X; Oren M; Vousden KH
    EMBO J; 1996 Feb; 15(4):827-38. PubMed ID: 8631304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle regulation and the p53 tumor suppressor protein.
    Mercer WE
    Crit Rev Eukaryot Gene Expr; 1992; 2(3):251-63. PubMed ID: 1511188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.